Get started
Author

Jonas Munksgaard Berg

Observed names: Berg, J. Munksgaard, Jonas M. Berg
ORCID: 0000-0001-9056-7470
Observed ORCID: 0000-0001-9056-7470
OpenAlex ID: A5003621182
Ocrelizumab treatment in multiple sclerosis: A Danish population‐based cohort study
2021 · Luigi Pontieri, Morten Blinkenberg, et al. · European Journal of Neurology · 29
PDF
Extended interval dosing with ocrelizumab in multiple sclerosis
2024 · Frederik Novak, Hamza Mahmood Bajwa, et al. · Multiple Sclerosis Journal · 27
PDF
Using extra systoles and the micro-fluid challenge to predict fluid responsiveness during cardiac surgery
2018 · Simon T. Vistisen, Jonas M. Berg, et al. · Journal of Clinical Monitoring and Computing · 15
Existing fluid responsiveness studies using the mini‐fluid challenge may be misleading: Methodological considerations and simulations
2021 · Johannes Enevoldsen, Thomas W. L. Scheeren, et al. · Acta Anaesthesiologica Scandinavica · 8
Discontinuation of dimethyl fumarate in multiple sclerosis - a nationwide study
2023 · Malte Roar, Amalie Rhode Høgh Nielsen, et al. · Multiple Sclerosis and Related Disorders · 7
Changes in arterial blood pressure characteristics following an extrasystolic beat or a fast 50 ml fluid challenge do not predict fluid responsiveness during cardiac surgery
2021 · Jonas M. Berg, Dorthe V. Nielsen, et al. · Journal of Clinical Monitoring and Computing · 1
PDF
Early experience with ocrelizumab in denmark. A population-based registry study
2020 · Melinda Magyari, Luigi Pontieri, et al. · VBN Forskningsportal (Aalborg Universitet) · 1
Between-hospital variation in discontinuation of treatment with dimethyl fumarate in multiple sclerosis
2026 · Hilde Norborg, Stephan Bramow, et al. · Multiple Sclerosis and Related Disorders
Extended dosage interval of B-cell therapy in multiple sclerosis
2021 · Novak, F., Østergaard, K., et al. · VBN Forskningsportal (Aalborg Universitet)
Works count: 9
Citation count: 88
H-index: 5
I10-index: 3
Year
Topic
Type